ADHD Drugmakers Warned About Misleading Promotions

The Food and Drug Administration has warned five manufacturers of drugs for attention-deficit/hyperactivity disorder against using what it terms “false or misleading” promotional materials that overstate the drugs' efficacy and downplay risks.